Lastly, anoikis resistance—the ability of detached cells to survive in circulation—is fortified by the Nrf2-driven antioxidant shield, which protects these circulating tumor cells from ROS-induced death, enabling their survival and subsequent metastatic seeding. The gene discussed is NFE2L2; the disease is neoplasm.